Pulmonx Corporation Insider Trading Activity
Pulmonx Corp. President and CEO Steven S. Williamson, who is also a director, reported selling small blocks of common stock on September 2, 2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Pulmonx Corp. President and CEO Steven S. Williamson, who is also a director, reported selling small blocks of common stock on September 2, 2025. He sold 5,118 shares at $1.60 per share and another 4,530 shares at $1.60 per share.
According to the footnotes, both sales were made to cover tax withholding obligations tied to the vesting of restricted stock units granted in March 2024 and March 2025. After these transactions, Williamson directly beneficially owned 358,967 shares of Pulmonx common stock, which includes 2,500 shares acquired under the company’s 2020 Employee Stock Purchase Plan on August 15, 2025.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 5,118 | $1.60 | $8K |
| Sale | Common Stock | 4,530 | $1.60 | $7K |
Footnotes (3)
- F1. These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on March 15, 2024.
- F2. Includes 2,500 shares acquired by the Reporting Person under the Issuer's 2020 Employee Stock Purchase Plan on August 15, 2025.
- F3. These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 3, 2025.
AI-generated analysis. How Rhea-AI works. Not financial advice.